Sandesh Seth, Chairman & CEO at Actinium Pharmaceuticals, Inc. (ATNM), bought 33,333 shares at $0.75 ($25K) on 2017-08-02, disclosed to the SEC on 2017-08-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ATNM | BUY | 2018-04-20 | $2K | — | Filing → |
| ATNM | BUY | 2017-06-15 | $9K | — | Filing → |
| ATNM | BUY | 2017-01-03 | $4K | — | Filing → |